FDA Approves Omisirge as First Approved Cell Therapy to Treat Severe Aplastic Anemia

Dec 8, 2025 - 23:00
 0  1
LONDON – December 5, 2025 – Ayrmid Ltd. (“Ayrmid” or the “Company”), the parent company of Gamida Cell Inc., a leader in cell therapy innovation announces that it has received U.S. Food and Drug Administration...

What's Your Reaction?

Like Like 0
Dislike Dislike 0
Love Love 0
Funny Funny 0
Angry Angry 0
Sad Sad 0
Wow Wow 0